These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 23613635)
1. Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus. Zhang H; Gao C; Fang L; Yao SK World J Gastroenterol; 2013 Apr; 19(15):2395-403. PubMed ID: 23613635 [TBL] [Abstract][Full Text] [Related]
2. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection. Gao C; Fang L; Zhao HC; Li JT; Yao SK Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496 [TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. Gao C; Zhao HC; Li JT; Yao SK World J Gastroenterol; 2010 Sep; 16(35):4467-75. PubMed ID: 20845516 [TBL] [Abstract][Full Text] [Related]
4. Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China. Li X; Xu H; Gao P Med Sci Monit; 2018 Sep; 24():6729-6734. PubMed ID: 30245503 [TBL] [Abstract][Full Text] [Related]
5. Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus. Zhang WS; Li XO; Zhang H; Gao C; Fang L; Yang HY Diabetes Metab Syndr Obes; 2020; 13():1979-1988. PubMed ID: 32606857 [TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478 [TBL] [Abstract][Full Text] [Related]
7. Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China. Xu C; Chen J; Zhang PA Med Sci Monit; 2019 Oct; 25():8112-8119. PubMed ID: 31661471 [TBL] [Abstract][Full Text] [Related]
8. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study. Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056 [TBL] [Abstract][Full Text] [Related]
9. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. El-Serag HB; Richardson PA; Everhart JE Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191 [TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391 [TBL] [Abstract][Full Text] [Related]
12. Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma. Abe H; Aida Y; Ishiguro H; Yoshizawa K; Miyazaki T; Itagaki M; Sutoh S; Aizawa Y World J Gastroenterol; 2013 Jan; 19(1):78-85. PubMed ID: 23326166 [TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. Hsiang JC; Gane EJ; Bai WW; Gerred SJ J Gastroenterol Hepatol; 2015 Mar; 30(3):591-9. PubMed ID: 25250942 [TBL] [Abstract][Full Text] [Related]
14. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
15. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma]. Zhang LL; Li YF; Zhang C; Wu XF; Ma Y; Li L Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):788-792. PubMed ID: 31734994 [No Abstract] [Full Text] [Related]
16. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States. Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436 [TBL] [Abstract][Full Text] [Related]
18. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924 [TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. Zheng Z; Zhang C; Yan J; Ruan Y; Zhao X; San X; Mao Y; Sun Q; Zhang K; Fan Z PLoS One; 2013; 8(12):e84776. PubMed ID: 24386416 [TBL] [Abstract][Full Text] [Related]
20. Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Chao LT; Wu CF; Sung FY; Lin CL; Liu CJ; Huang CJ; Tsai KS; Yu MW Carcinogenesis; 2011 Jun; 32(6):876-81. PubMed ID: 21464041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]